Intuitive Surgical (Nasdaq: ISRG) announced they have acquired Orpheus Medical, a company that provides hospitals with information technology connectivity and expertise in processing and archiving surgical video....
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that it has received final approval from the U.S. Food and Drug Administration (“FDA”) for its novel product...
Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, announced that Kevin Peters, M.D., Aerpio’s Chief Scientific Officer, pre...
Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye...
Below is the most recent corporate presentation for Dare Bioscience:...
Endologix, Inc. (the “Company”) (NASDAQ: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that its preliminary unaudited revenue for the fourth quarter ended December 31, 2019 is expected to be approximat...
According to the medtechy company forums, as well as Cafepharma, Warsaw, IN based Zimmer Biomet (NYSE:ZBH) is rumored to have had significant layoffs this week....
Well known venture capital firm, Andreessen Horowitz, announced they have launched their third bio fund, called BioFund III, years after saying they would never "do bio" as the firm's primary focus concentrates on investments ...
Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies, today announced that Nestlé Health Science...
Onconova Therapeutics (Nasdaq: ONTX) has had a rough start to the year with their stock down 35% so far in 2020. The company announced a $10 million stock offering at the end of December, which has continued weighing on the stock even after closing in early January...